Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
49
Frequently Asked Questions
What is Market Cap of Oculis Holding AG?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Oculis Holding AG market cap is $935.8M.
What is the 52-week high for Oculis Holding AG?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Oculis Holding AG 52 week high is $23.08 as of September 06, 2025.
What is the 52-week low for Oculis Holding AG?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oculis Holding AG 52 week low is $11.56 as of September 06, 2025.
What is Oculis Holding AG stock price today?
Oculis Holding AG stock price today is $17.22.
What was Oculis Holding AG stock price yesterday?
Oculis Holding AG stock price yesterday was $17.16.
What is the PE ratio of Oculis Holding AG?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Oculis Holding AG’s P/E ratio is -6.42.
What is the Price-to-Book ratio of Oculis Holding AG?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Oculis Holding AG P/B ratio is 5.2056.
What is the 50-day moving average of Oculis Holding AG?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Oculis Holding AG 50-day moving average is $17.97.
